Year: 2018
Type: review
Abstract: Disruption in the metabolism of lipids is broadly classified under dyslipidemia and relates to the concentration of lipids in the blood. Dyslipidemia is a predictor of cardio-metabolic disease including obesity. Traditionally, the large interindividual variation has been related to genetic factors and diet. Genome-wide association studies have identified over 150 loci related to abnormal lipid levels, explaining ~40% of the total variation. Part of the unexplained variance has been attributed to environmental factors including diet, but the extent of the dietary contribution remains unquantified. Furthermore, other factors are likely to influence lipid metabolism including the gut microbiome, which plays an important role in the digestion of different dietary components including fats and polysaccharides. Here we describe the contributing role of host genetics and the gut microbiome to dyslipidemia and discuss the potential therapeutic implications of advances in understanding the gut microbiome to the treatment of dyslipidemia.
Source: Physiological Genomics
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Awards: Diet-induced Arrangement of the gut Microbiome for improvement of Cardiometabolic health, NIHR Senior Investigator Award, G2960067629, G3207356259, G393177772, Health and Environment-wide Associations based on Large population Surveys, G5702163051, Ancestry and biological Informative Markers for stratification of HYpertension: The AIM HY study (Joint funding with MRC), Exploring host-gut microbial genetic and immune interactions using twins, MICA: Ancestry and biological Informative Markers for stratification of HYpertension: The AIM HY study, NIHR Senior Investigator Award
OpenAlex ID: W2780750033
